Tag: GMP

Creating Dosage-Form Specific GMP Training Modules for Operators and Supervisors Step-by-Step Guide to Creating Dosage-Form Specific GMP Training Modules for Operators and Supervisors Implementing effective Good Manufacturing Practice (GMP) training tailored for specific dosage forms is critical for pharmaceutical manufacturing compliance and quality assurance. Considering the diversity of dosage forms, including solid oral, parenteral, topical,…

Read More “Creating Dosage-Form Specific GMP Training Modules for Operators and Supervisors” »

Blueprint for a Dosage-Form–Specific GMP Program Covering Solids, Liquids, Sterile and Topicals Step-by-Step Blueprint for a Dosage-Form–Specific GMP Program Covering Solids, Liquids, Sterile and Topicals Good Manufacturing Practice (GMP) programs must be robust and tailored to the unique requirements of each pharmaceutical dosage form to ensure product quality, patient safety, and regulatory compliance. This tutorial…

Read More “Blueprint for a Dosage-Form–Specific GMP Program Covering Solids, Liquids, Sterile and Topicals” »

Blister vs Bottle Packaging: GMP Implications for Solid Orals Blister vs Bottle Packaging: GMP Implications for Solid Orals In the pharmaceutical industry, the packaging of solid oral dosage forms such as tablets and capsules plays a pivotal role not only in patient compliance and drug stability but also in regulatory compliance under Good Manufacturing Practice…

Read More “Blister vs Bottle Packaging: GMP Implications for Solid Orals” »

Unit-Dose Liquid Packaging: GMP for Form–Fill–Seal and BFS Technologies Comprehensive GMP Guide for Unit-Dose Liquid Packaging Using Form–Fill–Seal and BFS Technologies Pharmaceutical manufacturing and packaging demand rigorous adherence to Good Manufacturing Practice (GMP) standards, particularly when producing diverse dosage forms such as solid oral presentations, parenteral injectables, and topical products. Recent advances in unit-dose liquid…

Read More “Unit-Dose Liquid Packaging: GMP for Form–Fill–Seal and BFS Technologies” »

Bulk Bottle Filling for Orals: GMP for Counting, Induction Sealing and Labelling Bulk Bottle Filling for Orals: Step-by-Step GMP Guide for Counting, Induction Sealing, and Labelling In pharmaceutical manufacturing, maintaining compliance with Good Manufacturing Practice (GMP) regulations is critical, particularly when filling solid oral dosage forms such as tablets and capsules into bulk bottles. This…

Read More “Bulk Bottle Filling for Orals: GMP for Counting, Induction Sealing and Labelling” »

Tamper-Evident and Child-Resistant Packaging: GMP Integration Integrating Tamper-Evident and Child-Resistant Packaging within Pharmaceutical GMP for Diverse Dosage Forms The integration of tamper-evident and child-resistant packaging within pharmaceutical Good Manufacturing Practice (GMP) systems is an essential component of product quality and patient safety. Regulatory agencies across the US, UK, and EU, including the FDA, EMA, and…

Read More “Tamper-Evident and Child-Resistant Packaging: GMP Integration” »

Secondary Packaging for High-Risk Dosage Forms: Segregation and Labelling Effective Secondary Packaging of High-Risk Dosage Forms: Segregation and Labelling Best Practices In pharmaceutical manufacturing, secondary packaging plays a pivotal role in ensuring drug product integrity, patient safety, and regulatory compliance. This is particularly critical for high-risk dosage forms such as solid oral products (tablets and…

Read More “Secondary Packaging for High-Risk Dosage Forms: Segregation and Labelling” »

GMP Considerations for Co-Located API and Finished-Dose Manufacturing Step-by-Step GMP Considerations for Co-Located API and Finished-Dose Manufacturing The pharmaceutical manufacturing landscape often necessitates the co-location of Active Pharmaceutical Ingredient (API) production with finished-dosage-form manufacturing facilities. This integrated approach offers benefits such as reduced logistics complexity, faster product turnaround, and tighter supply chain control. However, it…

Read More “GMP Considerations for Co-Located API and Finished-Dose Manufacturing” »

Scaling Up Dosage Forms From Clinical to Commercial: GMP Pitfalls Step-by-Step Guide to Scaling Up Dosage Forms with GMP Compliance Scaling up pharmaceutical dosage forms from clinical to commercial production is a complex process that demands strict adherence to GMP requirements across different dosage forms including solid oral, parenteral, and topical products. This tutorial provides…

Read More “Scaling Up Dosage Forms From Clinical to Commercial: GMP Pitfalls” »

Scaling Up Dosage Forms From Clinical to Commercial: GMP Pitfalls Scaling Up Dosage Forms from Clinical to Commercial Production: Key GMP Considerations Scaling up pharmaceutical dosage forms from clinical trial manufacturing to commercial production represents a critical inflection point in product development. This transition presents a complex set of Good Manufacturing Practice (GMP) challenges—ranging from…

Read More “Scaling Up Dosage Forms From Clinical to Commercial: GMP Pitfalls” »